Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the influence of genetic polymorphisms of OCTN1 and OCT2 and
other possible covariates on the kinetic disposition of GAB in patients undergoing GAB
chronic treatment. Thus, patients treated with GAB, for at least one week, are being
investigated.